#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Plasma cell myeloma refractory Chondrosarcoma Inflammatory myofibroblastic tumour Infertility female Anaplastic thyroid cancer Primary biliary cholangitis Haemophilia B without inhibitors Post transplant lymphoproliferative disorder Langerhans' cell histiocytosis Arginase deficiency Frostbite Myocarditis B-cell small lymphocytic lymphoma Uveal melanoma Arteriovenous malformation More trials…

    Learn about Rare Diseases

    Osteosarcoma recurrent – Basic Information Mantle cell lymphoma – Treatment Usher’s syndrome – Life with Disease Prader-Willi syndrome – Treatment Gaucher’s disease type III – Trials in Disease Lysosomal storage disorder – Basic Information Andersen-Tawil syndrome – Basic Information Burkitt’s lymphoma – Life with Disease Alport’s syndrome – Life with Disease Congenital hypotransferrinaemia – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Somapacitan Trometamol Img-007 Ltx-315 4-Hydroxy-N-Desmethyltamoxifen Cabotegravir Utreloxastat Atropine Sulfate Nilotinib Poractant Alfa Florbetaben (18F) Iclepertin Tegafur Bomedemstat Kd050 Cinnarizine Rtx001 Enalapril Glepaglutide Lamotrigine More therapies…

    Learn about Your Condition

    Stevens-Johnson syndrome Vesicoureteric reflux Psychogenic seizure Biliary tract disorder Renal cancer stage IV Epstein-Barr virus infection Pancreaticoduodenectomy Corticobasal degeneration Large cell lung cancer Sickle cell disease Metastases to peritoneum Laparotomy Breast cancer stage II Mantle cell lymphoma stage III Alpha-1 antitrypsin deficiency More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Tolna Vármegyei Balassa János Kórház

Tolna Vármegyei Balassa János Kórház

Beri Balogh Adam Utca 5-7, Szekszard, 7100, Hungary

Want to learn more about this study or check if you can participate? Contact us.

  • A study of palazestrant and ribociclib compared to letrozole and ribociclib for patients with advanced ER+ HER2- breast cancer

    Recruiting

    3 1 1
    Investigated Drugs:
    • Op-1250
    • PALAZESTRANT
    • Letrozole
    Austria Belgium Czechia France Germany Greece +7

  • Stroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)

    Not yet recruiting

    3 1
    Investigated Drugs:
    • Regn7508
    • Regn9933
    Germany Hungary Latvia Portugal Sweden

  • Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Apixaban
    • Regn7508
    Czechia Greece Hungary Latvia The Netherlands

  • A study of the safety and efficacy of AC01 in patients with heart failure with reduced ejection fraction

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Heart failure with reduced ejection fraction
    Bulgaria Czechia Germany Hungary Italy The Netherlands +4

  • Study of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

    Not yet recruiting

    3 1
    Austria Belgium Bulgaria Czechia Denmark France +11

  • Efficacy Comparison of Zanzalintinib (XL092) and Pembrolizumab Versus Pembrolizumab Monotherapy in PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • N-(4-Fluorophenyl)-N-(4-((7-Methoxy-6-(Methylcarbamoyl)Quinolin-4- Yl)Oxy)Phenyl)Cyclopropane-1,1-Dicarboxamide
    • Pembrolizumab
    Austria Belgium Bulgaria Czechia France Germany +7

  • A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Abemaciclib
    • Leuprorelin Acetate
    • Anastrozole
    Austria Belgium Bulgaria Croatia Czechia Estonia +10

  • Study Comparing Acasunlimab and Pembrolizumab with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Acasunlimab
    • Anakinra
    • Betamethasone Sodium Phosphate
    Austria Belgium Bulgaria Croatia Estonia France +9

  • Study of Eftilagimod Alfa with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Eftilagimod Alfa
    • Carboplatin
    • Cisplatin
    Austria Belgium Bulgaria Croatia Germany Greece +9

  • Study of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • Breast cancer
    Investigated Drugs:
    • Fulvestrant
    • Pf-07220060 Monohydrate
    • Everolimus
    Belgium Bulgaria Czechia Denmark Finland France +8
Previous Page
1 2 3 4 5 6
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!